Reuters logo
BRIEF-Staidson Beijing BioPharmaceuticals unit to invest $20 mln in fund
August 23, 2017 / 1:28 AM / 4 months ago

BRIEF-Staidson Beijing BioPharmaceuticals unit to invest $20 mln in fund

Aug 23(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Says its wholly owned unit STAIDSON HONG KONG INVESTMENT COMPANY LIMITED plans to invest $20 million in New China Innovation Fund SPC acting for the account of New China Innovation Fund 14 Segregated Portfolio, which will mainly invest in overseas pharmaceutical related projects

Source text in Chinese: goo.gl/Lkdw86

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below